Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Blood|June 8, 2017
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical responseMichael D Amatangelo, Lynn Quek, Alan Shih, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in VivoJaneta Popovici-Muller, Jeffrey O Saunders, Francesco G Salituro, et al.
Genes & Development|August 29, 2012
D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane functionMasato Sasaki, Christiane B Knobbe, Momoe Itsumi, et al.
Journal of Medicinal Chemistry|February 9, 2026
Discovery and Optimization of Orally Bioavailable Heterobifunctional Degraders of KAT2A/B for the Treatment of CancerJames Neef, Kimberly S Straley, Chinmoy Mukherjee, et al.
Journal of Neuro-Oncology|October 22, 2011
Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopyWhitney B Pope, Robert M Prins, M Albert Thomas, et al.
Nature|November 26, 2009
Cancer-associated IDH1 mutations produce 2-hydroxyglutarateLenny Dang, David W White, Stefan Gross, et al.
Science (New York, N.Y.)|April 6, 2013
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cellsDan Rohle, Janeta Popovici-Muller, Nicolaos Palaskas, et al.
Pageof 2